139 related articles for article (PubMed ID: 11075962)
1. Hepatocellular carcinoma : treated with hepatic arterial embolization, an analysis of prognostic features in 150 cases.
Eurvilaichit C; Kanjanapitak A
J Med Assoc Thai; 2000 Sep; 83(9):983-91. PubMed ID: 11075962
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma: a multivariate analysis of prognostic features in patients treated with hepatic arterial embolization.
Shijo H; Okazaki M; Higashihara H; Koganemaru F; Okumura M
Am J Gastroenterol; 1992 Sep; 87(9):1154-9. PubMed ID: 1325736
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
[TBL] [Abstract][Full Text] [Related]
4. [Transarterial oil chemoembolization for hepatocellular carcinoma, in 100 cases].
Levy I; Verstandig A; Sasson T; Wolf D; Krichon I; Libson E; Levensart P; Papo O; Yurim O; Id A; Shouval D
Harefuah; 2000 Jan; 138(2):89-93, 174. PubMed ID: 10883065
[TBL] [Abstract][Full Text] [Related]
5. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series.
Takano S; Watanabe Y; Ohishi H; Kono S; Nakamura M; Kubota N; Iwai S
Eur J Surg Oncol; 2000 Feb; 26(1):67-72. PubMed ID: 10718183
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in resected hepatocellular carcinomas and therapeutic value of transcatheter arterial embolization for recurrences.
Kimura H; Yabushita K; Konishi K; Maeda K; Kuroda Y; Tsuji M; Demachi H; Miwa A
Int Surg; 1998; 83(2):146-9. PubMed ID: 9851333
[TBL] [Abstract][Full Text] [Related]
7. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
8. [Oily chemoembolization of hepatoma].
Nakamura H; Hashimoto T; Taguchi T; Oi H; Inoue K; Seki K; Mizumoto S; Tsukaguchi I; Araki Y; Sawada S
Gan To Kagaku Ryoho; 1987 Feb; 14(2):381-7. PubMed ID: 3028276
[TBL] [Abstract][Full Text] [Related]
9. [Transcatheter arterial embolization with hepatic arterial induction of endogenous TNF in hepatocellular carcinoma].
Takekoshi H; Oyama R
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2845-8. PubMed ID: 2476966
[TBL] [Abstract][Full Text] [Related]
10. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
Fan J; Wu Z; Tang Z
Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
[TBL] [Abstract][Full Text] [Related]
11. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of hepatocellular carcinoma by transarterial approach].
Luo PF
Zhonghua Yi Xue Za Zhi; 1993 Mar; 73(3):158-60, 191. PubMed ID: 8391913
[TBL] [Abstract][Full Text] [Related]
13. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of combinated transcatheter hepatic artery chemoembolization and factors affecting the prognosis in patients with primary hepatic carcinoma].
Li CX; Zhang Y; Gao L
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):942-5. PubMed ID: 17533749
[TBL] [Abstract][Full Text] [Related]
15. Management of spontaneous bleeding due to hepatocellular carcinoma.
Recordare A; Bonariol L; Caratozzolo E; Callegari F; Bruno G; Di Paola F; Bassi N
Minerva Chir; 2002 Jun; 57(3):347-56. PubMed ID: 12029230
[TBL] [Abstract][Full Text] [Related]
16. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
Kang IK; Kim SW; Hahn SH; Cho SC; Gham CW; Lee DH
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):189-200. PubMed ID: 12499805
[TBL] [Abstract][Full Text] [Related]
17. [Chemoembolization].
Nakamura H; Hashimoto T; Taguchi T; Oi H; Nakagawa K; Inoue K; Seki K; Mizumoto S; Akashi H; Tsukaguchi I
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1656-63. PubMed ID: 3036013
[TBL] [Abstract][Full Text] [Related]
18. Hepatic resection for bilobar hepatocellular carcinoma: is it justified?
Liu CL; Fan ST; Lo CM; Ng IO; Poon RT; Wong J
Arch Surg; 2003 Jan; 138(1):100-4. PubMed ID: 12511161
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
[TBL] [Abstract][Full Text] [Related]
20. Gigantic hepatocellular carcinoma, treated by transcatheter oily chemoembolization (TOCE) and wedge hepatic resection.
Eurvilaichit C; Kanjanapitak A; Leopairut J
J Med Assoc Thai; 2000 May; 83(5):554-63. PubMed ID: 10863903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]